Birchview Capital’s Karyopharm Therapeutics KPTI Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$121K	Hold	27,985	–	–	0.12%	64
2025 Q1	$105K	Sell	27,985 -391,847	-93%	-$1.47M	0.09%	62
2024 Q4	$284K	Sell	419,832 -50,000	-11%	-$33.8K	0.23%	50
2024 Q3	$390K	Hold	469,832	–	–	0.34%	35
2024 Q2	$408K	Hold	469,832	–	–	0.38%	34
2024 Q1	$709K	Hold	469,832	–	–	0.58%	29
2023 Q4	$406K	Sell	469,832 -102,000	-18%	-$88.2K	0.32%	37
2023 Q3	$766K	Buy	571,832 +280,500	+96%	+$376K	0.65%	26
2023 Q2	$521K	Hold	291,332	–	–	0.39%	36
2023 Q1	$1.13M	Hold	291,332	–	–	0.89%	18
2022 Q4	$991K	Buy	291,332 +22,000	+8%	+$74.8K	0.7%	22
2022 Q3	$1.47M	Hold	269,332	–	–	1.04%	20
2022 Q2	$1.22M	Hold	269,332	–	–	0.88%	20
2022 Q1	$1.99M	Buy	269,332 +23,332	+9%	+$172K	1.43%	13
2021 Q4	$1.58M	Hold	246,000	–	–	1.02%	18
2021 Q3	$1.43M	Buy	246,000 +16,000	+7%	+$93.1K	0.97%	19
2021 Q2	$2.37M	Hold	230,000	–	–	1.42%	11
2021 Q1	$2.42M	Buy	230,000 +42,000	+22%	+$442K	1.44%	13
2020 Q4	$2.91M	Buy	188,000 +20,000	+12%	+$310K	1.68%	12
2020 Q3	$2.45M	Hold	168,000	–	–	1.64%	10
2020 Q2	$3.18M	Buy	168,000 +20,000	+14%	+$379K	1.92%	8
2020 Q1	$2.84M	Buy	148,000 +68,000	+85%	+$1.31M	2.52%	7
2019 Q4	$1.53M	Buy	80,000 +10,000	+14%	+$192K	1.12%	10
2019 Q3	$673K	Hold	70,000	–	–	0.45%	22
2019 Q2	$419K	Hold	70,000	–	–	0.25%	35
2019 Q1	$409K	Hold	70,000	–	–	0.26%	35
2018 Q4	$656K	Buy	70,000 +20,000	+40%	+$187K	0.62%	20
2018 Q3	$852K	Hold	50,000	–	–	0.55%	20
2018 Q2	$850K	Buy	+50,000	New	+$850K	0.58%	20